Based on the strong effects of GSK-3β inhibition on the stem/progenitor cell subpopulation in vitro, we evaluated the effects of GIN pretreatment on prostate cancer tumorigenicity and metastatic potential in vivo. Here, GSK3B is linked to prostate carcinoma.